Cargando…

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosé, Adriana, André, Nicolas, Rozados, Viviana R., Mainetti, Leandro E, Márquez, Mauricio Menacho, Rico, María José, Schaiquevich, Paula, Villarroel, Milena, Gregianin, Lauro, Graupera, Jaume Mora, García, Wendy Gómez, Epelman, Sidnei, Alasino, Carlos, Alonso, Daniel, Chantada, Guillermo, Scharovsky, O Graciela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014555/
https://www.ncbi.nlm.nih.gov/pubmed/27610198
http://dx.doi.org/10.3332/ecancer.2016.672
_version_ 1782452311164977152
author Rosé, Adriana
André, Nicolas
Rozados, Viviana R.
Mainetti, Leandro E
Márquez, Mauricio Menacho
Rico, María José
Schaiquevich, Paula
Villarroel, Milena
Gregianin, Lauro
Graupera, Jaume Mora
García, Wendy Gómez
Epelman, Sidnei
Alasino, Carlos
Alonso, Daniel
Chantada, Guillermo
Scharovsky, O Graciela
author_facet Rosé, Adriana
André, Nicolas
Rozados, Viviana R.
Mainetti, Leandro E
Márquez, Mauricio Menacho
Rico, María José
Schaiquevich, Paula
Villarroel, Milena
Gregianin, Lauro
Graupera, Jaume Mora
García, Wendy Gómez
Epelman, Sidnei
Alasino, Carlos
Alonso, Daniel
Chantada, Guillermo
Scharovsky, O Graciela
author_sort Rosé, Adriana
collection PubMed
description Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and researchers with experience in the field of metronomics, coming from different countries in Latin America, had the opportunity of presenting and discussing their work. The talks were organised in three main sessions related to experience in the pre-clinical, and clinical (paediatric and adult) areas. The different presentations demonstrated that the fields of metronomic chemotherapy and repurposing drugs in oncology, known as metronomics, constitute a branch of cancer therapy in permanent evolution, which have strong groups working in Latin America, both in the preclinical and the clinical settings including large, adequately designed randomised studies. It was shown that metronomics offers treatments, which, whether they are combined or not with the standard therapeutic approaches, are not only effective but also minimally toxic, with the consequent improvement of the patient’s quality of life, and inexpensive, a feature very important in low resource clinical settings. The potential use of metronomic chemotherapy was proposed as a cost/effective treatment in low-/middle-income countries, for adjuvant therapy in selected tumours. The fundamental role of the governmental agencies and non-governmental alliances, as the Metronomic Global Health Initiative, in supporting this research with public interest was underlined.
format Online
Article
Text
id pubmed-5014555
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-50145552016-09-08 Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina Rosé, Adriana André, Nicolas Rozados, Viviana R. Mainetti, Leandro E Márquez, Mauricio Menacho Rico, María José Schaiquevich, Paula Villarroel, Milena Gregianin, Lauro Graupera, Jaume Mora García, Wendy Gómez Epelman, Sidnei Alasino, Carlos Alonso, Daniel Chantada, Guillermo Scharovsky, O Graciela Ecancermedicalscience Conference Report Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and researchers with experience in the field of metronomics, coming from different countries in Latin America, had the opportunity of presenting and discussing their work. The talks were organised in three main sessions related to experience in the pre-clinical, and clinical (paediatric and adult) areas. The different presentations demonstrated that the fields of metronomic chemotherapy and repurposing drugs in oncology, known as metronomics, constitute a branch of cancer therapy in permanent evolution, which have strong groups working in Latin America, both in the preclinical and the clinical settings including large, adequately designed randomised studies. It was shown that metronomics offers treatments, which, whether they are combined or not with the standard therapeutic approaches, are not only effective but also minimally toxic, with the consequent improvement of the patient’s quality of life, and inexpensive, a feature very important in low resource clinical settings. The potential use of metronomic chemotherapy was proposed as a cost/effective treatment in low-/middle-income countries, for adjuvant therapy in selected tumours. The fundamental role of the governmental agencies and non-governmental alliances, as the Metronomic Global Health Initiative, in supporting this research with public interest was underlined. Cancer Intelligence 2016-09-06 /pmc/articles/PMC5014555/ /pubmed/27610198 http://dx.doi.org/10.3332/ecancer.2016.672 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Conference Report
Rosé, Adriana
André, Nicolas
Rozados, Viviana R.
Mainetti, Leandro E
Márquez, Mauricio Menacho
Rico, María José
Schaiquevich, Paula
Villarroel, Milena
Gregianin, Lauro
Graupera, Jaume Mora
García, Wendy Gómez
Epelman, Sidnei
Alasino, Carlos
Alonso, Daniel
Chantada, Guillermo
Scharovsky, O Graciela
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title_full Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title_fullStr Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title_full_unstemmed Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title_short Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
title_sort highlights from the 1st latin american meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 may, 2016, rosario, argentina
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014555/
https://www.ncbi.nlm.nih.gov/pubmed/27610198
http://dx.doi.org/10.3332/ecancer.2016.672
work_keys_str_mv AT roseadriana highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT andrenicolas highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT rozadosvivianar highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT mainettileandroe highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT marquezmauriciomenacho highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT ricomariajose highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT schaiquevichpaula highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT villarroelmilena highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT gregianinlauro highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT grauperajaumemora highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT garciawendygomez highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT epelmansidnei highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT alasinocarlos highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT alonsodaniel highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT chantadaguillermo highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina
AT scharovskyograciela highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina